Farag Kameel D. bought AKTX
October 22, 2025 · Form 4 insider transaction
Farag Kameel D. bought 6,277 shares of Akari Therapeutics, Plc at $0.74 per share, a transaction worth $4.6K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,277
Price
$0.74
Total value
$4.6K
InsiderFarag Kameel D.
Role—
SecurityAmerican Depositary Shares representing Ordinary Shares
Transaction codeA: Grant or award
Transaction dateOctober 22, 2025
Filing dateOctober 24, 2025
Shares owned after6,277
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer; These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on October 31, 2025.